scPharmaceuticals Inc.

NASDAQ: SCPH · Real-Time Price · USD
3.85
-0.12 (-3.02%)
At close: Jun 26, 2025, 11:21 AM
-3.02%
Bid 3.82
Market Cap 203.33M
Revenue (ttm) 41.98M
Net Income (ttm) -90.78M
EPS (ttm) -1.92
PE Ratio (ttm) -2.01
Forward PE -14.67
Analyst Buy
Ask 3.89
Volume 30,571
Avg. Volume (20D) 386,190
Open 3.96
Previous Close 3.97
Day's Range 3.85 - 3.97
52-Week Range 1.94 - 5.65
Beta 0.36

About SCPH

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SCPH
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SCPH stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Next Earnings Release

scPharmaceuticals Inc. is scheduled to release its earnings on Aug 13, 2025, during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
1 month ago
+28.57%
scPharmaceuticals shares are trading higher after ... Unlock content with Pro Subscription
3 months ago
-1.89%
scPharmaceuticals shares are trading higher after the company announced FDA approval for a supplemental new drug application expanding the FUROSCIX indication to include the treatment of edema in patients with chronic kidney disease.